KHAYAL TAMER I (Chief Commercial Officer) sold 6.5% of their position (1.46K shares) of TRANSMEDICS GROUP, INC. on the open market
Open‑market sale worth $131.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/13/2024ACC: 0000950170-24-126397
Officer· Chief Commercial Officer
Since May 2019
-1.46K
Net shares
Net seller
$131.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.46K acquired · 2.92K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.46K
Price / share
$38.46
Trade value
$56.07K
% of position
7.0%
11/11/2024
20.84K→22.30K
Common Stock
Direct
Shares
−1.46K
Price / share
$90.04
Trade value
$131.28K
% of position
6.5%
11/11/2024
22.30K→20.84K
Total
Net shares
+0.00
Net value
-$75.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/11/2024 | M · Option Exercise | +1.46K | $38.46 | $56.07K | 7.0% | 20.84K | 22.30K |
| Common Stock Direct | 11/11/2024 | S · Sale | −1.46K | $90.04 | $131.28K | 6.5% | 22.30K | 20.84K |
| Total | +0.00 | -$75.20K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.46K shares
Shares
−1.46K
Strike price
38.46
Held after
5.83K
Exercisable
—
11/11/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.46K shares | 11/11/2024 | M · Option Exercise | −1.46K | 38.46 | — | 5.83K |